Company Hyundai Pharmaceutical Co., Ltd.

Equities

A004310

KR7004310009

Pharmaceuticals

End-of-day quote Korea S.E. 23:00:00 08/05/2024 BST 5-day change 1st Jan Change
3,790 KRW -0.26% Intraday chart for Hyundai Pharmaceutical Co., Ltd. +0.26% -7.79%

Business Summary

HYUNDAI PHARMACEUTICAL CO.,LTD is a Korea-based company principally engaged in the manufacture and distribution of pharmaceuticals and beverages. The Company mainly provides two categories of products: pharmaceuticals, including ophthalmological tablets, clopidogrel bisulfate, mirtazapine tablets and others, which are applied in the treatment of depressive disorder, hypertension, hemostatics and others, as well as healthcare food products, including vitamin products, calcium supplements and others. It also provides dietary various beverages and medical equipment. The Company mainly distributes its products within domestic market. In addition, the Company also involves in the leasing business.

Number of employees: 393

Sales per Business

KRW in Million2022Weight2023Weight Delta
Medicine
78.3 %
130,945 80.5 % 141,510 78.3 % +8.07%
Food
21.7 %
31,745 19.5 % 39,253 21.7 % +23.65%

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
100.0 %
162,690 100.0 % 180,763 100.0 % +11.11%

Managers

Managers TitleAgeSince
Chief Executive Officer 47 27/02/03
Director of Finance/CFO 67 07/05/89
Director/Board Member 62 22/10/07
Sales & Marketing 57 30/11/94
Sales & Marketing 55 30/11/95
Corporate Officer/Principal 62 26/07/87

Members of the board

Members of the board TitleAgeSince
Chairman 76 09/08/74
Director/Board Member 77 04/02/99
Chief Executive Officer 47 27/02/03
Director/Board Member 62 22/10/07
Director/Board Member 50 11/02/15
Director/Board Member 74 10/02/19
Director/Board Member 58 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 32,000,000 18,866,419 ( 58.96 %) 5,627,620 ( 17.59 %) 58.96 %

Shareholders

NameEquities%Valuation
Han-Gu Lee
17.88 %
5,720,290 17.88 % 16 M ₩
5,232,471 16.35 % 15 M ₩
1,351,612 4.224 % 4 M ₩
Bioinnotis
0.7265 %
232,471 0.7265 % 668 273 ₩
126,642 0.3958 % 364 051 ₩
A&PEP Co. Ltd.
0.1906 %
61,000 0.1906 % 175 354 ₩
Hyundai Pharmaceutical Co., Ltd. ESOA
0.1303 %
41,710 0.1303 % 119 902 ₩
Dimensional Fund Advisors Ltd.
0.0204 %
6,532 0.0204 % 18 777 ₩
Mirae Asset Global Investments Co., Ltd.
0.003922 %
1,255 0.003922 % 3 608 ₩
DFA Australia Ltd.
0.001716 %
549 0.001716 % 1 578 ₩

Holdings

NameEquities%Valuation
5,232,471 16.35% 15,041,523 $
488,000 2.62% 5,270,581 $

Company contact information

Hyundai Pharmaceutical Co., Ltd.

55 Jandari-gil Pungse-myeon

31213, Cheonan

+

http://www.hyundaipharm.co.kr
address Hyundai Pharmaceutical Co., Ltd.(A004310)
  1. Stock Market
  2. Equities
  3. A004310 Stock
  4. Company Hyundai Pharmaceutical Co., Ltd.